Tag: digital pathology funding

HalioDx closed a Series B round of €18.5 million (US$22.3 million)

| January 17, 2018 | 0 Comments

This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial activities in the US This round was led by PSIM fund managed by Bpifrance in the framework of the program ‘Investing for the Future’ Marseille, France, January 17, 2018 – HalioDx, a diagnostic company expert in the analysis […]

Continue Reading